Singapore markets close in 7 hours 10 minutes
  • Straits Times Index

    3,299.23
    +12.90 (+0.39%)
     
  • Nikkei

    27,819.33
    -180.63 (-0.65%)
     
  • Hang Seng

    19,849.80
    +238.96 (+1.22%)
     
  • FTSE 100

    7,507.11
    +18.96 (+0.25%)
     
  • BTC-USD

    24,315.75
    +1,437.66 (+6.28%)
     
  • CMC Crypto 200

    573.36
    +42.14 (+7.93%)
     
  • S&P 500

    4,210.24
    +87.77 (+2.13%)
     
  • Dow

    33,309.51
    +535.11 (+1.63%)
     
  • Nasdaq

    12,854.80
    +360.88 (+2.89%)
     
  • Gold

    1,803.20
    -10.50 (-0.58%)
     
  • Crude Oil

    91.67
    -0.26 (-0.28%)
     
  • 10-Yr Bond

    2.7860
    -0.0110 (-0.39%)
     
  • FTSE Bursa Malaysia

    1,502.76
    +10.43 (+0.70%)
     
  • Jakarta Composite Index

    7,086.24
    -16.64 (-0.23%)
     
  • PSE Index

    6,544.51
    +72.67 (+1.12%)
     

Is AbbVie About To Get A New Blockbuster Drug?

·3-min read
Is AbbVie About To Get A New Blockbuster Drug?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

AbbVie recently applied for FDA approval of its advanced Parkinson's disease drug candidate. This could be huge considering it's set to lose market exclusivity of Humira.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting